The increase in non-communicable chronic diseases has aroused interest in the research of
adjuvants to the classic forms of treatments. Obesity and metabolic syndrome are the main …

Diabetes has become a “lifestyle disease” and is growing epidemically on an alarming rate.
It has become a serious socio-economic burden on the developed and under developed …

In the search for new proteinase inhibitors we have focused on the screening and Computer
Assisted Drug Design (CADD) studies of polyphenolic compounds. In this paper we report …

Trypsin inhibitors from tamarind seed have been studied in vitro and in preclinical studies for
the treatment of obesity, its complications and associated comorbidities. It is still necessary …

Obesity is a major public health concern and environmental factors are involved in its
development. The hypothalamus is a primary site for the integration of signals for the …

Obesity is a disorder of lipid metabolism and continues to be a global problem, ranking fifth
for deaths worldwide. It also leads to diabetes, cardiovascular disorders, musculoskeletal …

The purpose of this Special Issue is to present the impact in clinical practice as well as in
medical research of novel molecules that have been introduced in the treatment of diabetes …

Human tryptase is a structurally unique and mast cell specific trypsin-like serine protease.
Recent biological and immunological investigations have implicated tryptase as a mediator …

Simple Summary Dietary habits and sedentary lifestyle are widely established to be the
major risk factors for the development of long-term chronic conditions, such as type-2 …

Obesity is a “multi-metabolic and hormonal disease state” that primarily results from an
imbalanced physiological energy homeostasis. There is a wide range of factors that play …